TEHR vs OpenLoop: Scope, Pricing and Migration

What does the current OpenLoop product actually include?

OpenLoop’s current proposition is wider than a roster of clinicians. Its Launchpad page describes a no-code storefront, intake, branded patient portal, clinical network, fulfillment, billing and communications. It also describes integrating clinical infrastructure into systems a customer already operates. That makes the first buying question one of configuration: do you want a new patient-facing experience, or do you want to preserve your existing one?

TEHR’s proposed role is similarly broad: technology and administration for a brand, connected to independent clinical services and pharmacy coordination. Its operator background is relevant when discussing exceptions, recurring orders and a real patient transition. It is not evidence that every competing platform lacks those capabilities. Compare a concrete service map against the TEHR platform, identifying who handles checkout problems, incomplete intake, clinical escalations, failed payments and pharmacy delays.

A useful demo follows one patient from acquisition through a second order. Ask each team to show the operational queue when something goes wrong. A polished storefront proves that a transaction can begin; the exception workflow shows what your staff must do after launch.

How do the documented capabilities compare?

All competitor statements below are dated as of October 22, 2026 and reflect the cited public pages. “Not stated on reviewed pages” means an unanswered question, not an absent capability. TEHR’s column describes its service model; program-specific scope belongs in the proposal.

How should you evaluate clinical and fulfillment responsibilities?

OpenLoop’s pharmacy and diagnostics page describes fulfillment, laboratory connections and at-home collection. Those are meaningful services, but a network description does not tell you the price or availability of a specific treatment. Request the proposed program list, permitted states, visit requirements, pharmacy options and responsibility for abnormal results.

For TEHR, the same questions apply. Clinical decisions stay with independent licensed providers; a brand cannot purchase an approval rate or direct prescribing. A white-label experience can carry your identity while still identifying the real medical practice and dispensing pharmacy wherever required. Treat this as part of the product design, not a legal paragraph to hide after checkout.

If you are evaluating future peptide programs, distinguish infrastructure readiness from authorization to prescribe or dispense. TEHR’s selected peptide programs remain pending and are not open for prescribing or fulfillment. OpenLoop’s page also describes compound-specific and state-specific restrictions. A category label is not a blanket availability statement.

What does a fair cost comparison include?

The reviewed OpenLoop product pages do not provide a universal numeric rate card or establish its revenue-share terms. That is an information gap to resolve with a proposal, not permission to invent a percentage. TEHR states a flat platform subscription plus a flat transaction fee and 0% revenue share; contact TEHR for a scoped quote for actual subscription and transaction amounts.

Build a monthly model using the same completed-visit volume, order frequency and treatment mix for both proposals. Separate platform fees, clinical services, medications, laboratory costs, shipping, card processing, support and implementation. Then model an unsuccessful clinical assessment, a refund and a replacement shipment. Those events reveal charges that a successful-order example can conceal.

Use the TEHR pricing page and TEHR pricing calculator to organize assumptions, not to create an unsupported savings claim. A lower line item may accompany a different responsibility boundary. The relevant number is the cost of delivering your intended service with your actual team.

What changes when existing patients need to move?

An OpenLoop integration option does not establish a standard process for exporting an existing brand’s records into TEHR. Before discussing cutover dates, obtain the current contract, available export formats and a sample of each relevant data type. Patient demographics alone are not a complete transition: active treatment, clinical notes, consents, labs, prescription history, billing state and unresolved support cases each need an owner.

Use a small representative group to test record matching and clinical review before moving a whole population. Confirm what happens to patients due for a refill during the transition and how the old and new teams will avoid duplicate billing. Payment credentials should move only through approved processor procedures; assume neither that tokens transfer automatically nor that every patient must re-enter a card.

Our OpenLoop migration guide and patient migration checklist describe the planning work. TEHR’s operator team reports moving thousands of its own patients; that history is not a universal deadline for your migration.

How should you interpret launch timelines?

OpenLoop advertises launches in days, with its Launchpad FAQ describing some launches in as little as a day. Attribute that as a vendor estimate and ask what the starting conditions are. A preselected program with complete brand materials is a different project from a custom intake, unusual pharmacy arrangement or multi-program migration.

For a fair comparison, define a launch acceptance checklist: contracted entities, approved program configuration, working payment flow, tested communications, clinical routing, pharmacy connectivity and support escalation. Then ask each vendor to estimate against that same checklist. TEHR should provide a scoped schedule rather than countering a fast headline with an unsupported promise.

A functional website is one milestone. A brand is operationally ready when the first eligible patient can complete the intended journey and the team can handle the first exception.

When should you choose TEHR or OpenLoop?

Choose TEHR for further evaluation if you want to work with the operators behind DudeMeds, Peptiders, TellyMeds and FansMeds, value a stated flat-fee commercial model, and want launch or migration responsibilities written around your operation. Confirm support coverage, actual pricing and any specialty-specific dependencies before signing.

Choose OpenLoop for further evaluation if its documented Launchpad experience, broader program configuration or existing-stack integration matches your operating model. Its public platform description is strong evidence of a turnkey option; dismissing it as staffing-only would produce a poor decision.

If neither proposal is the right fit, use OpenLoop alternatives to compare different operating models. A clinical API can be appropriate for a team with its own software, while an integrated brand platform may be preferable for a team that wants fewer systems to manage.

What should you request before making the decision?

Ask for an itemized proposal, a responsibility map and a demonstration using your actual program requirements. Record unresolved questions with an owner and a due date. Review the resource library for related definitions and operating checklists, then bring the current workflow and intended changes to a scoped discussion. A useful agreement identifies what the vendor will deliver, what your team must supply, how exceptions are handled and what evidence will demonstrate readiness. It should also explain the practical exit process, so future changes do not depend on assumptions about records, subscriptions or access.

For a wider category view, compare the white-label telehealth platform shortlist and the turnkey telehealth platform shortlist. Use the first to examine brand and architecture choices, and the second to assess which implementation and operating tasks a proposed package actually supplies.

What else should you know?